The COVID-19 pandemic did not just disrupt pharmaceutical supply chains; it exposed structural weaknesses that made it difficult to ensure medication access during a crisis. Health-system pharmacies faced critical drug shortages, allocation bottlenecks, and fractured distribution channels that impacted patient care across all settings.
As we move forward, pharmacy leaders have an opportunity and a responsibility to rebuild with intention. The goal is not just to recover but to create smarter, more connected, and future-ready systems that ensure continuous access to medications no matter the challenge.
From Transactional to Strategic
Historically, pharmacy supply chains focused on price negotiations and basic inventory management; however, the current landscape demands more. Today, supply chain decisions influence everything from patient access and care transitions to satisfaction and revenue cycle performance.
The rising complexity of payer rules, specialty drug distribution, and limited networks has redefined what it means to manage pharmacy operations. Leaders must now coordinate across retail, ambulatory, and specialty settings to optimize purchasing and ensure uninterrupted therapy.The strategies that these leaders must implement can be grouped into three pillars: resilience, agility, and alignment.
Pillar one: Resilience
Resilience means building supply chains that can weather disruption without compromising care. In outpatient settings, this requires striking a balance between just-in-time inventory and the need for consistent access to high-cost medications. Forward-thinking health systems are implementing multisource procurement strategies, including secondary wholesalers and direct manufacturer relationships, to create backup channels and reduce dependency on any sole source. These partnerships often bring both security and competitive pricing. Specialty pharmacies need smart inventory systems that track utilization trends, manage prior authorizations, and avoid excess stock while ensuring timely fulfillment, especially for limited distribution drugs that cannot always be sourced through traditional channels.
Pillar two: Agility
Agility is the ability to pivot quickly in response to change, whether it’s a new insurance requirement, a product recall, or a supply chain disruption. For pharmacy leaders, that means building systems that support fast, coordinated action.
Effective outpatient operations use streamlined prior authorization workflows, automated refill systems, and responsive patient communication to stay ahead of potential delays. When a shortage hits, teams can quickly activate therapeutic substitutions or alternate sourcing strategies.
Data analytics is playing a growing role here, helping predict inventory needs based on refill patterns, patient volumes, and seasonal demand. The ability to act proactively, not reactively, is what separates agile pharmacy operations from the rest.
Pillar three: Alignment
Most critical is strategic alignment. Pharmacy supply chain decisions should reflect and support broader organizational goals, from care coordination to population health.
This strategy includes aligning formularies across care settings, supporting clinic-based specialty services, and ensuring that patients receive cost-effective therapies without unnecessary delays. Health-system-owned pharmacies are also investing in services like home delivery, medication synchronization, and patient assistance program enrollment to improve access and adherence.
These offerings do not just enhance the patient experience; they support the organization’s mission and longterm sustainability.
Building the Future
Rebuilding the pharmacy supply chain is not just about process; it’s about people and technology. Success requires integrated inventory systems, specialty pharmacy platforms, and welltrained staff who understand the intersection of clinical care, payer dynamics, and procurement.
Pharmacy leaders must be versatile. That means understanding operational workflows, contracting strategies, and the broader healthcare ecosystem, all while fostering strong relationships with suppliers, clinicians, and internal stakeholders.
Artificial intelligence and machine learning are also emerging as powerful enablers. These technologies can analyze historical data and patient trends to improve demand forecasting, flag potential shortages early, and guide procurement decisions in real time.
The Road Ahead
Health-system pharmacies will continue to face headwinds from rising drug costs, the threat of tariffs, impending active pharmaceutical ingredient (API) shortages, reimbursement pressure, and ongoing consolidation in the market. With these headwinds comes an unprecedented opportunity to lead.
Those who build resilient, agile, and aligned supply chains (supported by technology and grounded in strong supplier relationships) will be best positioned to navigate the challenges ahead.
As we rebuild, we are not just solving for today. We are designing supply chains that can stand up to whatever tomorrow brings, while keeping patients at the center of everything we do. When the supply chain works, both patient care and business performance move forward together.
